IV fluid choices in children: have we found the solution?
نویسندگان
چکیده
منابع مشابه
IV fluid choices in children: have we found the solution?
a e s r f w a f a f There have been at least 15 randomized controlled trials (RCTs) published on the isotonic versus hypotonic maintenance fluid debate in the last decade, the most recent of which was the trial conducted by Valadão et al.,1 published in this issue of Jornal de Pediatria. Based on a concern that children undergoing surgery are at particular risk of hospital-acquired hyponatremia...
متن کاملHave we found the surgical solution for ischemic mitral regurgitation?
The article by deVarennes et al in the current issue of Circulation details the outcomes in 44 patients with severe (4 ) Carpentier type IIIb ischemic mitral regurgitation undergoing mitral valve repair consisting of posterior leaflet extension with bovine pericardium, coupled with remodeling annuloplasty, with or without coronary revascularization.1 Dissatisfied with the long-term results of a...
متن کاملStatins: have we found the Holy Grail?
In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.
متن کاملIntravenous fluid choices in critically ill children.
PURPOSE OF REVIEW To review the past year's literature, and selected prior literature relevant to these most recent findings, regarding intravenous fluid choices in the management of critically ill children. RECENT FINDINGS Twenty-eight publications were identified using the keywords pediatrics and intravenous fluid in the PubMed database. The subjects identified included intravenous fluid ch...
متن کاملSelective allodepletion: have we finally found the holy grail?
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment option for patients with hematologic malignancies and nonmalignant disorders of hematopoiesis. Outcomes of allogeneic HSCT have improved steadily over the decades [1]. However, significant challenges remain. One of these challenges is the so-called Holy Grail of stem cell transplantation immunology: to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Jornal de Pediatria
سال: 2015
ISSN: 0021-7557
DOI: 10.1016/j.jped.2015.05.001